Skip to nav Skip to content

CDC/IDSA COVID-19 Clinician Call: COVID-19 Outcomes in Immunosuppressed Individuals with Autoimmune Disease; Variants Q&A

Facebook Twitter LinkedIn Email

To Download a copy of the presentation click here.

To Download a copy of the Q&A Responses click here.

*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.


Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA

Topics and Featured Experts:

• Jinoos Yazdany, MD, MPH
Co-director, Lupus Clinic
Chief of the Division of Rheumatology
Zuckerberg San Francisco General Hospital and
the Alice Betts Endowed Professor of Medicine at UCSF

Variants Q&A

• Judith A. Aberg, MD, FIDSA, FACP
Chief Division of Infectious Diseases
George Baehr Professor of Medicine at Icahn School of Medicine at Mount Sinai

• Gregory Armstrong, MD, FIDSA
Director, Advanced Molecular Detection Program
Centers for Disease Control and Prevention

Latest Media

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.